Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Others observations: Therapeutic alternatives: chlorothiazide, chlorthalidone, indapamide. |
| WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
Others observations: Therapeutic alternatives: chlorothiazide, chlorthalidone, indapamide. |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Others observations: Therapeutic alternatives: chlorothiazide, chlorthalidone, indapamide. |
| Peru | 16. Diuretics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Others observations: Therapeutic alternatives: chlorothiazide, chlorthalidone, indapamide. |
| WHO Model List of Essential Medicines (2021) | 12.4. Medicines used in heart failure |
Others observations: Therapeutic alternatives: chlorothiazide, chlorthalidone, indapamide. |
| WHO Model List of Essential Medicines (2021) | 16. DIURETICS |
Others observations: Therapeutic alternatives: chlorothiazide, chlortalidone, indapamide. |
| Peru | 12.3 Anti-Hypertensives | No observations |
| Peru | 12.4 Medications Used in Cardiac Insufficiency | No observations |
| Peru | 16. Diuretics | No observations |
| Colombia | 05.5 Diuretics | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines | No observations |
| Cuba | 16. DIURÉTICOS | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 16. DIURETICS |
This medicine requires a children care specialist. Others observations: Therapeutic alternatives: chlorothiazide, chlortalidone |